Home
Rachel McMinn, CEO: Neurogene NGNE Sell · Filed 03/30
Trade details
- Type
- Insider sale
- Amount
- $73,978.64
- Shares · price
- 3,352 sh · $22.07 a share
- Held after
- 1,344,307 sh
- Stock
- Neurogene NGNE
- Person
- Rachel McMinnCEO
- Trade date
- 26/03/26
- Filed
- 26/03/30
- Days to filing
- 4 days
Sold 0.2% of holdings
- Share of holding sold
- 0.2%
Neurogene trades, last 26 weeks
What else happened in Neurogene around then
Filed or reported within 30 days of the trade day · 02/24~04/25Rachel McMinn's recent trades
- Rachel McMinn
BuyNeurogene
BuyNeurogene
NGNE
$969K
47,500 sh
$969K
Filed 24/11/25
Traded 24/11/22